ストックスクリーナーアプリを入手
23.09
5.62%
-1.375
前日終値:
$24.46
開ける：
$23.95
24時間の取引高:
94,641
Relative Volume:
0.12
時価総額：
$1.39B
収益：
$688.00K
当期純損益:
$-170.19M
株価収益率:
-7.5701
EPS:
-3.0495
ネットキャッシュフロー:
$-154.68M
1週間 パフォーマンス:
-6.04%
1か月 パフォーマンス:
+45.28%
6か月 パフォーマンス:
+52.78%
1年 パフォーマンス:
-32.06%
1日の値動き範囲:
$23.01
$24.45
1週間の範囲:
$23.01
$25.05
52週間の値動き範囲:
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
SYRE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
23.09 | 1.90B | 688.00K | -170.19M | -154.68M | -3.0495 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.12 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
828.79 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-26 | 開始されました | Deutsche Bank | Buy |
| 2025-04-08 | 開始されました | Leerink Partners | Outperform |
| 2025-03-18 | 開始されました | Wolfe Research | Outperform |
| 2024-09-04 | 開始されました | Wedbush | Outperform |
| 2024-07-16 | 開始されました | Evercore ISI | Outperform |
| 2024-05-02 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-01 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | 開始されました | BTIG Research | Buy |
| 2023-12-11 | 開始されました | Guggenheim | Buy |
| 2023-12-11 | 開始されました | Jefferies | Buy |
| 2020-05-04 | 開始されました | Piper Sandler | Overweight |
| 2019-03-21 | 開始されました | JP Morgan | Overweight |
| 2018-09-04 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | 開始されました | Evercore ISI | Outperform |
| 2018-03-14 | 繰り返されました | Needham | Buy |
すべてを表示
Spyre Therapeutics Inc (SYRE) 最新ニュース
Why Spyre Therapeutics Inc. stock is seen as undervaluedWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Using data tools to time your Spyre Therapeutics Inc. exitJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Why retail investors favor Spyre Therapeutics Inc. stock2025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
Is Spyre Therapeutics Inc. stock a buy for dividend growthJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com
Can Spyre Therapeutics Inc. stock sustain free cash flow growthShare Buyback & AI Powered Market Entry Strategies - newser.com
Will Spyre Therapeutics Inc. (3920) stock sustain uptrend momentumWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com
What dividend safety score for Spyre Therapeutics Inc. stock2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Why Spyre Therapeutics Inc. stock remains on watchlistsPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
Using Ichimoku Cloud for Spyre Therapeutics Inc. technicalsMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
How to escape a deep drawdown in Spyre Therapeutics Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Is a relief rally coming for Spyre Therapeutics Inc. holdersWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Will Spyre Therapeutics Inc. stock recover faster than peers2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
What insider purchases suggest about Spyre Therapeutics Inc. (3920) stockMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Published on: 2025-11-02 03:35:20 - newser.com
Is Spyre Therapeutics Inc. (3920) stock inflation resilient2025 Analyst Calls & Risk Managed Investment Signals - newser.com
Why Spyre Therapeutics Inc. stock remains undervalued2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Will Spyre Therapeutics Inc. stock deliver strong dividend growth2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com
Earnings visualization tools for Spyre Therapeutics Inc.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
What sentiment indicators say about Spyre Therapeutics Inc. stock2025 Price Momentum & Long-Term Safe Return Strategies - newser.com
Published on: 2025-11-01 04:11:34 - newser.com
Spyre Therapeutics (SYRE) to Release Quarterly Earnings on Thursday - MarketBeat
Will Spyre Therapeutics Inc. stock maintain dividend yieldWeekly Trend Summary & Community Consensus Stock Picks - newser.com
What drives Spyre Therapeutics Inc 3920 stock priceInsider Buying Signals & Free Professional Investment Consultations - earlytimes.in
Will Spyre Therapeutics Inc. stock sustain high P E ratiosJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
Spyre Therapeutics, Inc. $SYRE Shares Sold by Emerald Mutual Fund Advisers Trust - MarketBeat
Best data tools to analyze Spyre Therapeutics Inc. stockJuly 2025 Action & Weekly Breakout Watchlists - newser.com
Is Spyre Therapeutics Inc. (3920) stock at risk of policy regulationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Is Spyre Therapeutics Inc. (3920) stock undervalued after correctionMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Will Spyre Therapeutics Inc. (3920) stock beat international competitionJuly 2025 Setups & Weekly Watchlist for Hot Stocks - newser.com
Backtesting results for Spyre Therapeutics Inc. trading strategiesQuarterly Investment Review & Community Trade Idea Sharing - newser.com
Spyre Therapeutics Inc (SYRE) 財務データ
収益
当期純利益
現金流量
EPS
0.21%
0.74%
大文字化:
|
ボリューム (24 時間):